Patent 10092584 was granted and assigned to Achillion Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.
Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduce the excessive activation of complement.